Experimental drug reverses severe fatty liver disease by repairing the gut
An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could open the door to a new class of treatments for MASH and potentially other diseases tied to gut
An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could open the door to a new class of treatments for MASH and potentially other diseases tied to gut This story matters for Health & Wellness readers tracking wellness. Reported by sciencedaily.com. Read the full original at the source link below.
Originally reported by sciencedaily.com. WellnessNews curates and briefs the health & wellness stories that matter. Our editorial policy →